API-2
- Mebendazole
- Milbemycin Oxime
- Monensin 20% / 40% / 90%
- Moxidectin
- Neostigmine Methylsufate
- Ponazuril
- Praziquantel
- Pyrantel Pamoate
- Rafoxanide
- Robenacoxib
- Spinosad
- Toltrazuril
- Tulathromycin
All products that are currently under patent protection can only be used for R&D and scientific research purposes when sold to the destination country market, and the buyer will bear the relevant responsibilities.